Endothelin Converting Enzyme
ECE-1 assists in the regulation of vascular tone and blood pressure through its involvement in the endothelin system. ECE-1 is a membrane-integrated metalloproteinase with an extracellular zinc-binding active site. It is responsible for the final step of converting big endothelins into the biologically active forms. ECE-1 activity affects several physiological processes, namely vasoconstriction, cell proliferation, inflammation and fibrosis. It is widely expressed in human tissues with notably high levels in vascular endothelial cells. Dysregulation of ECE-1 is implicated in several pathological conditions- hypertension and cardiac disease, chronic kidney failure, cancer and Alzheimer’s disease. The possibility of impacting these disease states makes it an attractive target for drug development.
This Endothelin Converting Enzyme is manufactured in USA by Eagle Biosciences.
| Size | |
| Sensitivity | < 1 µU/well |
| Sample Type | Heart, Kidney & Cell Lysates, Tissue Lysates Including Lung |
| Storage | -20°C |



